Although MVA85A boosting leads to strongly increased Ag85A specific, IFN-γ producing CD4+ T cells responses in BCG vaccines [19], protection against tuberculosis could not be increased by this boosting regimen in infants in a rural area near Cape Town, South Africa [20]. The gene discussed is CD4; the disease is tuberculosis.